Gabriel Newman

Gabriel is the CEO of the UK-based subsidiary of Cantourage SE, a publicly listed company. With their extensive knowledge of the medical cannabis industry, he and his team have established a specialised cannabis importation and distribution business. In addition, they co-founded the Cantourage cannabis clinic, where they have helped numerous patients obtain safe and effective cannabis treatments. Gabriel is enthusiastic about educating individuals on the therapeutic potential of cannabis and is committed to addressing the stigma that continues to surround the plant. Leveraging his perspective as both a CEO and a patient advocate, Gabriel offers valuable insights into the challenges and opportunities confronting the medical cannabis industry.